Attomarker can help avoid the onset of type 2 diabetes as well as help other conditions such as food allergies and HIV.
Attomarker technology being showcased at London Science Museum
Attomarker, a pioneering spin-out company based at the University of Exeter, is featured in an exhibition at the Science Museum in London.
Attomarker has developed the world’s first “pocket blood-testing laboratory”, providing a comprehensive and easy way to monitor, manage and help combat some of the biggest health challenges of today.
Attomarker is currently being displayed in the “Medicine: The Wellcome Galleries” exhibition at the Science Museum amongst other significant medical developments, including the first MRI scanner and the first sample of penicillin. From ancient and established to new, Attomarker is being exhibited as an example of medical technology of the future.
As well as helping patients avoid the onset of type-2 diabetes and identify and manage their food allergies, Attomarker can also help map, monitor and combat epidemics of HIV & TB and, crucially, play a crucial role in fight against antimicrobial resistance by helping cut the inappropriate use of antibiotics.
University of Exeter academic, Professor Andrew Shaw, the company’s founder and CEO, said: “It’s an incredible honour to have our technology alongside some of the great names of science such as Watson and Crick and next to the first penicillin sample. The work in the laboratory progresses well and we will be testing our ideas in the clinic in 2020.”
The ground-breaking company recently won the “One to Watch” award at the annual OBN Life Sciences event, held in Oxford.
Date: 19 November 2019